-+ 0.00%
-+ 0.00%
-+ 0.00%

GALECTIN THERAPEUTICS INC: Q2 NET LOSS PER SHARE $0.14 - SEC FILING

Reuters·08/14/2026 11:58:19

Please log in to view news